REGENXBIO INC's ticker is RGNX and the CUSIP is 75901B107. A total of 179 filers reported holding REGENXBIO INC in Q2 2018. The put-call ratio across all filers is 0.69 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $21,525,000 | +20.2% | 300,000 | -50.0% | 0.05% | +16.7% |
| Q1 2018 | $17,910,000 | +26.7% | 600,000 | +41.2% | 0.04% | +31.2% |
| Q4 2017 | $14,131,000 | -9.7% | 425,000 | -10.5% | 0.03% | -15.8% |
| Q3 2017 | $15,651,000 | +143.8% | 475,000 | +46.2% | 0.04% | +137.5% |
| Q2 2017 | $6,419,000 | +2.3% | 325,000 | 0.0% | 0.02% | 0.0% |
| Q1 2017 | $6,273,000 | -3.4% | 325,000 | -7.1% | 0.02% | -11.1% |
| Q4 2016 | $6,493,000 | +164.8% | 350,000 | +100.0% | 0.02% | +157.1% |
| Q3 2016 | $2,452,000 | +513.0% | 175,000 | +250.0% | 0.01% | +600.0% |
| Q2 2016 | $400,000 | -25.9% | 50,000 | 0.0% | 0.00% | 0.0% |
| Q1 2016 | $540,000 | -34.9% | 50,000 | 0.0% | 0.00% | -50.0% |
| Q4 2015 | $830,000 | -49.8% | 50,000 | -33.3% | 0.00% | -60.0% |
| Q3 2015 | $1,652,000 | – | 75,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RTW INVESTMENTS, LP | 1,459,128 | $110,164,000 | 6.60% |
| ArchPoint Investors | 224,187 | $16,926,000 | 4.60% |
| Redmile Group, LLC | 1,656,065 | $125,033,000 | 3.85% |
| WS MANAGEMENT LLLP | 954,812 | $72,088,000 | 2.37% |
| HIGHLINE CAPITAL MANAGEMENT, L.P. | 342,000 | $25,821,000 | 1.19% |
| Perceptive Advisors | 470,672 | $35,536,000 | 0.95% |
| Pier Capital, LLC | 94,492 | $7,134,000 | 0.90% |
| Ipswich Investment Management Co., Inc. | 29,932 | $2,260,000 | 0.76% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 275,000 | $20,763,000 | 0.74% |
| Timpani Capital Management LLC | 27,835 | $2,102,000 | 0.61% |